Share Twitter LinkedIn Facebook Email Rafael Fonseca, M.D. Clinical Investigator For The Damon Runyon Cancer Research Fund Discusses MAIA Study, AMG 420 Compound, KRD Transplant At The 60th ASH Annual Meeting on Dec 1, 2018.
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read